Publications by the researcher in collaboration with Verónica Blanco (14)

2024

  1. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma

    Cells, Vol. 13, Núm. 1

  2. Experimental Models of Sinonasal Tumors for Preclinical Testing of Candidate Targeted Therapies

    Current Otorhinolaryngology Reports, Vol. 12, Núm. 1, pp. 1-10

  3. Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment

    International journal of molecular sciences, Vol. 25, Núm. 8

2023

  1. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling

    Biomedicine and Pharmacotherapy, Vol. 162

  2. Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer

    Biomedicines, Vol. 11, Núm. 10

  3. Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas

    Journal of Personalized Medicine, Vol. 13, Núm. 10

2022

  1. Intragenic NF1 deletions in sinonasal mucosal malignant melanoma

    Pigment Cell and Melanoma Research, Vol. 35, Núm. 1, pp. 88-96

2021

  1. Aberrant signaling pathways in sinonasal intestinal-type adenocarcinoma

    Cancers, Vol. 13, Núm. 19

  2. Mithramycin delivery systems to develop effective therapies in sarcomas

    Journal of Nanobiotechnology, Vol. 19, Núm. 1

  3. Prognostic relevance of cd4+, cd8+ and foxp3+ tils in oral squamous cell carcinoma and correlations with pd-l1 and cancer stem cell markers

    Biomedicines, Vol. 9, Núm. 6

2020

  1. EGFR mutation and HPV infection in sinonasal inverted papilloma and squamous cell carcinoma

    Rhinology, Vol. 58, Núm. 4, pp. 1-11

  2. GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β

    Cell Death and Disease, Vol. 11, Núm. 11

2019

  1. PD-L1 expression in tumor cells is an independent unfavorable prognostic factor in oral squamous cell carcinoma

    Cancer Epidemiology Biomarkers and Prevention, Vol. 28, Núm. 3, pp. 546-554

2015

  1. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival

    Virchows Archiv, Vol. 466, Núm. 5, pp. 549-558